Washington, Clive
AstraZeneca,
United Kingdom
2025 Rank: 122808
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 1125 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122808 | 132763 |
| Total Cites | 2445 | 2608 |
| H-index | 26 | 27 |
| Hm-index | 15 | 17 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 695 | 712 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 1079 | 1126 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 1681 | 1756 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1987 | 2071 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
6.25%
|
|
Washington, Clive
AstraZeneca,
United Kingdom
2024 Rank: 117052
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 1083 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117052 | 125160 |
| Total Cites | 2372 | 2534 |
| H-index | 25 | 27 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 680 | 697 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 1054 | 1101 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 1640 | 1715 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1921 | 2004 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
6.39%
|
|
Washington, Clive
AstraZeneca,
United Kingdom
2023 Rank: 108987
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 1031 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108987 | 118290 |
| Total Cites | 2310 | 2472 |
| H-index | 25 | 27 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 660 | 677 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 1027 | 1074 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 1592 | 1667 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1871 | 1954 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.27 |
| Self-Citation Percentage |
6.55%
|
|
Washington, Clive
AstraZeneca,
United Kingdom
2022 Rank: 103330
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 982 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103330 | 110103 |
| Total Cites | 2243 | 2405 |
| H-index | 25 | 26 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 643 | 660 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 1005 | 1052 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 1553 | 1628 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1809 | 1892 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
6.74%
|
|
Washington, Clive
AstraZeneca,
United Kingdom
2021 Rank: 99243
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 958 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 99243 | 107269 |
| Total Cites | 2187 | 2348 |
| H-index | 25 | 26 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 624 | 641 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 980 | 1027 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 1512 | 1587 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1763 | 1845 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
6.86%
|
|
Washington, Clive
AstraZeneca,
United Kingdom
2020 Rank: 95754
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 881 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 95754 | 103171 |
| Total Cites | 2049 | 2205 |
| H-index | 24 | 25 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 595 | 609 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 933 | 976 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 1393 | 1464 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1661 | 1741 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.27 |
| Self-Citation Percentage |
7.07%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.